FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to surgery, and concerns preventing the abdominal adhesion formation following the intra-abdominal operations. To this effect, a laparotomic wound closure is preceded by administering Miramistin 3 ml/kg of body weight into the abdominal cavity. The preparation is left in the abdominal cavity for 5 hours and passively evacuated.
EFFECT: preparation dose schedule provides the effective prevention of the adhesion formation by the antiadhesive, antiseptic and microcirculation improving action of Miramistin.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREVENTION OF COMMISSURE FORMATION AND RELAPSE THEREOF | 2007 |
|
RU2331367C1 |
| METHOD FOR PREVENTING VISCEROPARIETAL ABDOMINAL COMMISSURES | 1998 |
|
RU2150897C1 |
| METHOD OF PREVENTING POSTOPERATIVE COMMISSURAL PROCESS IN ABDOMINAL CAVITY | 2009 |
|
RU2432944C2 |
| METHOD OF ADHESION THERAPY FOLLOWING THORACIC AND ABDOMINAL ORGANS SURGERY | 2006 |
|
RU2348415C2 |
| METHOD OF SIMULATING ADHESIVE PROCESSES IN ABDOMINAL CAVITY | 2016 |
|
RU2632538C1 |
| METHOD FOR TREATING THE CASES OF COMMISSURE DISEASE | 1998 |
|
RU2177741C2 |
| WAY PREVENTING POSTOPERATIVE ADHESIONS FORMATION | 2007 |
|
RU2363476C1 |
| METHOD FOR PREVENTING PERITONEAL ADHESIONS IN VENTRAL HERNIAS OF ABDOMINAL WALL | 2015 |
|
RU2610539C1 |
| METHOD OF PREVENTION OF POSTOPERATIVE ADHESIVE PROCESS OF PELVIC ORGANS | 2020 |
|
RU2745965C1 |
| AGENT FOR PROPHYLAXIS OF POSTOPERATIVE COMMISSURAL PROCESS | 2002 |
|
RU2227742C1 |
